Coupang Shares Fall 7.7% as Guidance Offsets Q2 Beat
Coupang shares tumbled 7.7% on softer guidance, erasing what the company's strongest quarterly earnings beat in recent memory had implied for the recovery thesis. With insiders having sold $3.2M above
Coupang Shares Fall 7.7% as Guidance Offsets Q2 Beat
NEW YORK, September 2 —
Coupang, Inc. (CPNG) beat Q2 EPS estimates by 69.4%, its strongest quarterly surprise in four quarters, and shares fell 7.7% on softer guidance. The beat arrived against a depressed consensus; the guidance apparently revealed what the EPS print obscured; and the insiders who sold in August at prices above the current level are now ahead of everyone still holding.
- Insiders sold $3.20M on August 10 at prices above the current $15.80 share price; zero insider purchases in 90 days.
- Wellington Management shed 861,979 shares; analyst consensus target of $23.66 sits roughly 50% above the current price.
What the Guidance Buried
Coupang operates South Korean retail, fresh grocery delivery via Rocket Fresh, and a digital advertising marketplace under Product Commerce, alongside Eats, Play streaming, and Farfetch luxury in Developing Offerings. But 3.9% revenue growth on $35.46bn in trailing sales, paired with a 58.7x forward P/E, demands guidance that justifies the multiple. The market's 7.7% response suggests it does not. Two of the four most recent quarters were misses; the beat arrived against a depressed consensus, not a rising bar.
Exit at $16, Hold at $15.80
Harold Rogers sold 192,110 shares at $16.18 on August 10, generating $3.11M. Chief Accounting Officer Jonathan D. Lee sold 5,519 shares at $16.10 the same day. Total insider open-market sales: $3.20M. Total insider purchases in 90 days: zero. Both prices sit above the current $15.80, meaning the stock has drifted below where insiders chose to sell. Wellington Management then shed 861,979 shares, and Kerrisdale Advisers also trimmed its position. With 84% institutional ownership, the pattern is not idiosyncratic; it is insiders and significant institutional holders moving in the same direction.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| CPNG | $28.4B | 58.7x | -43.5% |
| RBLX | $29.1B | n/a | -67.9% |
| U | $18.0B | 23.5x | +6.8% |
| AFRM | $23.6B | 14.4x | -9.5% |
| DASH | $97.8B | 27.7x | -5.1% |
| UPST | $2.7B | 8.0x | -58.5% |
Where the Thesis Cracks
Coupang's balance sheet is not the issue: $6.11bn in cash against $5.63bn in debt, $1.425bn in trailing operating cash flow. The problem is the valuation. At 58.7x forward earnings on a trailing-loss business, the DCF math only holds if guidance supports a credible profitability path; it apparently does not yet. The number to watch next quarter: Product Commerce margin expansion toward breakeven. The analyst consensus of $23.66 sits 50% above the current price and embeds an earnings recovery that insiders did not wait for. Run the free Coupang, Inc. deep-dive → for the current numbers.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Coupang shares tumbled 7.7% on softer guidance, erasing what the company's strongest quarterly earnings beat in recent memory had implied for the recovery thesis. With insiders having sold $3.2M above the current price just days after the earnings filing, and Wellington Management now shedding 861,979 shares, the exit is broadening even as analyst targets sit roughly 50% above the stock.